1. Home
  2. TROO vs SCPH Comparison

TROO vs SCPH Comparison

Compare TROO & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TROO
  • SCPH
  • Stock Information
  • Founded
  • TROO 2005
  • SCPH 2013
  • Country
  • TROO Hong Kong
  • SCPH United States
  • Employees
  • TROO N/A
  • SCPH N/A
  • Industry
  • TROO Radio And Television Broadcasting And Communications Equipment
  • SCPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • TROO Technology
  • SCPH Health Care
  • Exchange
  • TROO Nasdaq
  • SCPH Nasdaq
  • Market Cap
  • TROO N/A
  • SCPH 173.6M
  • IPO Year
  • TROO N/A
  • SCPH 2017
  • Fundamental
  • Price
  • TROO $0.66
  • SCPH $3.97
  • Analyst Decision
  • TROO
  • SCPH Strong Buy
  • Analyst Count
  • TROO 0
  • SCPH 3
  • Target Price
  • TROO N/A
  • SCPH $14.00
  • AVG Volume (30 Days)
  • TROO 47.0K
  • SCPH 289.9K
  • Earning Date
  • TROO 07-15-2025
  • SCPH 08-13-2025
  • Dividend Yield
  • TROO N/A
  • SCPH N/A
  • EPS Growth
  • TROO N/A
  • SCPH N/A
  • EPS
  • TROO N/A
  • SCPH N/A
  • Revenue
  • TROO $10,073,000.00
  • SCPH $41,982,000.00
  • Revenue This Year
  • TROO N/A
  • SCPH $108.95
  • Revenue Next Year
  • TROO N/A
  • SCPH $73.83
  • P/E Ratio
  • TROO N/A
  • SCPH N/A
  • Revenue Growth
  • TROO 182.24
  • SCPH 138.10
  • 52 Week Low
  • TROO $0.49
  • SCPH $1.94
  • 52 Week High
  • TROO $4.89
  • SCPH $5.65
  • Technical
  • Relative Strength Index (RSI)
  • TROO 42.17
  • SCPH 61.96
  • Support Level
  • TROO $0.65
  • SCPH $3.77
  • Resistance Level
  • TROO $1.00
  • SCPH $4.08
  • Average True Range (ATR)
  • TROO 0.06
  • SCPH 0.17
  • MACD
  • TROO -0.02
  • SCPH -0.04
  • Stochastic Oscillator
  • TROO 3.57
  • SCPH 76.92

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

Share on Social Networks: